Cargando…
TIMP3 Overexpression Improves the Sensitivity of Osteosarcoma to Cisplatin by Reducing IL-6 Production
Osteosarcoma is the most common bone cancer in children and adolescents. Tissue inhibitors of metalloproteinases (TIMPs)-3 inhibit matrix metalloproteinases to limit extracellular matrix degradation. Cisplatin is a widely used chemotherapeutic drug used to cure osteosarcoma. Interleukin (IL)-6 and T...
Autores principales: | Han, Xiu-guo, Mo, Hui-min, Liu, Xu-qiang, Li, Yan, Du, Lin, Qiao, Han, Fan, Qi-ming, Zhao, Jie, Zhang, Shu-hong, Tang, Ting-ting |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5920027/ https://www.ncbi.nlm.nih.gov/pubmed/29731768 http://dx.doi.org/10.3389/fgene.2018.00135 |
Ejemplares similares
-
IL-32 gamma reduces lung tumor development through upregulation of TIMP-3 overexpression and hypomethylation
por: Yun, Jaesuk, et al.
Publicado: (2018) -
CXCR1/Akt signaling activation induced by mesenchymal stem cell-derived IL-8 promotes osteosarcoma cell anoikis resistance and pulmonary metastasis
por: Du, Lin, et al.
Publicado: (2018) -
Anti-POSTN and Anti-TIMP1 Autoantibodies as Diagnostic Markers in Esophageal Squamous Cell Carcinoma
por: Xie, Weihong, et al.
Publicado: (2022) -
Effect of TIMP2/TIMP3 genes on the risk of osteosarcoma in Zhejiang population
por: Wu, Zhongwei, et al.
Publicado: (2021) -
TIMP-1 gene deficiency increases tumour cell sensitivity to chemotherapy-induced apoptosis
por: Davidsen, M L, et al.
Publicado: (2006)